Cargando…

Proactive versus Rank-Down Topical Corticosteroid Therapy for Maintenance of Remission in Pediatric Atopic Dermatitis: A Randomized, Open-Label, Active-Controlled, Parallel-Group Study (Anticipate Study)

Topical corticosteroids are used as first-line treatment for atopic dermatitis (AD). Regarding the maintenance of remission achieved by topical corticosteroids, no previous studies have compared proactive therapy with rank-down therapy. We compared their efficacy and safety in Japanese children with...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamiya, Koji, Saeki, Hidehisa, Tokura, Yoshiki, Yoshihara, Shigemi, Sugai, Junichi, Ohtsuki, Mamitaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658234/
https://www.ncbi.nlm.nih.gov/pubmed/36362704
http://dx.doi.org/10.3390/jcm11216477
_version_ 1784829900064030720
author Kamiya, Koji
Saeki, Hidehisa
Tokura, Yoshiki
Yoshihara, Shigemi
Sugai, Junichi
Ohtsuki, Mamitaro
author_facet Kamiya, Koji
Saeki, Hidehisa
Tokura, Yoshiki
Yoshihara, Shigemi
Sugai, Junichi
Ohtsuki, Mamitaro
author_sort Kamiya, Koji
collection PubMed
description Topical corticosteroids are used as first-line treatment for atopic dermatitis (AD). Regarding the maintenance of remission achieved by topical corticosteroids, no previous studies have compared proactive therapy with rank-down therapy. We compared their efficacy and safety in Japanese children with moderate to severe AD. Patients who had achieved remission with a very strong topical corticosteroid were randomized to 4-week maintenance treatment with either intermittent use of the same drug (proactive therapy) or daily use of a strong topical corticosteroid for 1 week followed by daily use of a medium-potency topical corticosteroid for 3 weeks (rank-down therapy); 49 patients were randomized (proactive therapy, n = 24; rank-down therapy, n = 25). During maintenance treatment, the relapse rate was 8.33% in the proactive therapy group and 20.0% in the rank-down therapy group (p = 0.0859). The mean (±standard deviation) itching score on a numerical rating scale in the rank-down therapy group increased significantly from 2.5 ± 1.9 to 3.6 ± 2.6 (p = 0.0438). Adverse events occurred in 2 patients receiving proactive therapy and 3 patients receiving rank-down therapy. Proactive therapy appears to be as safe as rank-down therapy and may be more effective for itch in pediatric AD in remission.
format Online
Article
Text
id pubmed-9658234
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96582342022-11-15 Proactive versus Rank-Down Topical Corticosteroid Therapy for Maintenance of Remission in Pediatric Atopic Dermatitis: A Randomized, Open-Label, Active-Controlled, Parallel-Group Study (Anticipate Study) Kamiya, Koji Saeki, Hidehisa Tokura, Yoshiki Yoshihara, Shigemi Sugai, Junichi Ohtsuki, Mamitaro J Clin Med Article Topical corticosteroids are used as first-line treatment for atopic dermatitis (AD). Regarding the maintenance of remission achieved by topical corticosteroids, no previous studies have compared proactive therapy with rank-down therapy. We compared their efficacy and safety in Japanese children with moderate to severe AD. Patients who had achieved remission with a very strong topical corticosteroid were randomized to 4-week maintenance treatment with either intermittent use of the same drug (proactive therapy) or daily use of a strong topical corticosteroid for 1 week followed by daily use of a medium-potency topical corticosteroid for 3 weeks (rank-down therapy); 49 patients were randomized (proactive therapy, n = 24; rank-down therapy, n = 25). During maintenance treatment, the relapse rate was 8.33% in the proactive therapy group and 20.0% in the rank-down therapy group (p = 0.0859). The mean (±standard deviation) itching score on a numerical rating scale in the rank-down therapy group increased significantly from 2.5 ± 1.9 to 3.6 ± 2.6 (p = 0.0438). Adverse events occurred in 2 patients receiving proactive therapy and 3 patients receiving rank-down therapy. Proactive therapy appears to be as safe as rank-down therapy and may be more effective for itch in pediatric AD in remission. MDPI 2022-10-31 /pmc/articles/PMC9658234/ /pubmed/36362704 http://dx.doi.org/10.3390/jcm11216477 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kamiya, Koji
Saeki, Hidehisa
Tokura, Yoshiki
Yoshihara, Shigemi
Sugai, Junichi
Ohtsuki, Mamitaro
Proactive versus Rank-Down Topical Corticosteroid Therapy for Maintenance of Remission in Pediatric Atopic Dermatitis: A Randomized, Open-Label, Active-Controlled, Parallel-Group Study (Anticipate Study)
title Proactive versus Rank-Down Topical Corticosteroid Therapy for Maintenance of Remission in Pediatric Atopic Dermatitis: A Randomized, Open-Label, Active-Controlled, Parallel-Group Study (Anticipate Study)
title_full Proactive versus Rank-Down Topical Corticosteroid Therapy for Maintenance of Remission in Pediatric Atopic Dermatitis: A Randomized, Open-Label, Active-Controlled, Parallel-Group Study (Anticipate Study)
title_fullStr Proactive versus Rank-Down Topical Corticosteroid Therapy for Maintenance of Remission in Pediatric Atopic Dermatitis: A Randomized, Open-Label, Active-Controlled, Parallel-Group Study (Anticipate Study)
title_full_unstemmed Proactive versus Rank-Down Topical Corticosteroid Therapy for Maintenance of Remission in Pediatric Atopic Dermatitis: A Randomized, Open-Label, Active-Controlled, Parallel-Group Study (Anticipate Study)
title_short Proactive versus Rank-Down Topical Corticosteroid Therapy for Maintenance of Remission in Pediatric Atopic Dermatitis: A Randomized, Open-Label, Active-Controlled, Parallel-Group Study (Anticipate Study)
title_sort proactive versus rank-down topical corticosteroid therapy for maintenance of remission in pediatric atopic dermatitis: a randomized, open-label, active-controlled, parallel-group study (anticipate study)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658234/
https://www.ncbi.nlm.nih.gov/pubmed/36362704
http://dx.doi.org/10.3390/jcm11216477
work_keys_str_mv AT kamiyakoji proactiveversusrankdowntopicalcorticosteroidtherapyformaintenanceofremissioninpediatricatopicdermatitisarandomizedopenlabelactivecontrolledparallelgroupstudyanticipatestudy
AT saekihidehisa proactiveversusrankdowntopicalcorticosteroidtherapyformaintenanceofremissioninpediatricatopicdermatitisarandomizedopenlabelactivecontrolledparallelgroupstudyanticipatestudy
AT tokurayoshiki proactiveversusrankdowntopicalcorticosteroidtherapyformaintenanceofremissioninpediatricatopicdermatitisarandomizedopenlabelactivecontrolledparallelgroupstudyanticipatestudy
AT yoshiharashigemi proactiveversusrankdowntopicalcorticosteroidtherapyformaintenanceofremissioninpediatricatopicdermatitisarandomizedopenlabelactivecontrolledparallelgroupstudyanticipatestudy
AT sugaijunichi proactiveversusrankdowntopicalcorticosteroidtherapyformaintenanceofremissioninpediatricatopicdermatitisarandomizedopenlabelactivecontrolledparallelgroupstudyanticipatestudy
AT ohtsukimamitaro proactiveversusrankdowntopicalcorticosteroidtherapyformaintenanceofremissioninpediatricatopicdermatitisarandomizedopenlabelactivecontrolledparallelgroupstudyanticipatestudy